Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 450 citing articles:

COVID-19: Abnormal liver function tests
Qingxian Cai, Deliang Huang, Hong Yu, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 566-574
Open Access | Times Cited: 1037
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 646
Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina, Fatemeh Akhlaghi
Drug Metabolism Reviews (2017) Vol. 49, Iss. 2, pp. 197-211
Open Access | Times Cited: 548
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin, Jiaofeng Huang, Ming-Fang Wang, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2082-2089
Closed Access | Times Cited: 478
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
Ferenc E. Mózes, Jenny Lee, Emmanuel Selvaraj, et al.
Gut (2021) Vol. 71, Iss. 5, pp. 1006-1019
Open Access | Times Cited: 357
The Effects of Physical Exercise on Fatty Liver Disease
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, et al.
Gene Expression (2017) Vol. 18, Iss. 2, pp. 89-101
Open Access | Times Cited: 243
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming‐Hua Zheng, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S17-S31
Open Access | Times Cited: 233
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 363-401
Open Access | Times Cited: 222
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
Yasaman Vali, Jenny Lee, Jérôme Boursier, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 252-262
Open Access | Times Cited: 212
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
Emir Muzurović, Dimitri P. Mikhailidis, Christos S. Mantzoros
Metabolism (2021) Vol. 119, pp. 154770-154770
Closed Access | Times Cited: 195
Nonalcoholic Fatty Liver Disease
Yan-Ci Zhao, Guojun Zhao, Ze Chen, et al.
Hypertension (2019) Vol. 75, Iss. 2, pp. 275-284
Open Access | Times Cited: 188
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction
David Nam, Julius Chapiro, Valérie Paradis, et al.
JHEP Reports (2022) Vol. 4, Iss. 4, pp. 100443-100443
Open Access | Times Cited: 140
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
Tomáš Hrnčíř, Tomáš Hrnčíř, Miloslav Kverka, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 957-957
Open Access | Times Cited: 132
The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
Sylwia Ziółkowska, Agata Binienda, Maciej Jabłkowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11128-11128
Open Access | Times Cited: 118
MAFLD: a multisystem disease
Rosaria Maria Pipitone, Carlo Ciccioli, G. Infantino, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 104
Metabolic Disorders in Menopause
Hye Gyeong Jeong, Hyuntae Park
Metabolites (2022) Vol. 12, Iss. 10, pp. 954-954
Open Access | Times Cited: 79
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 483-496
Open Access | Times Cited: 76
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
Neda Yahoo, Michael Dudek, Percy A. Knolle, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 538-551
Open Access | Times Cited: 63
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 41
Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review
Pegah Golabi, Cameron T. Locklear, Patrick Austin, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 27, pp. 6318-6318
Open Access | Times Cited: 157
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 149
Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review
Elina M. Petäjä, Hannele Yki‐Järvinen
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 5, pp. 633-633
Open Access | Times Cited: 133
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Marieke de Vries, Jan Westerink, Karin Kaasjager, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3842-3853
Open Access | Times Cited: 113
Nonalcoholic Fatty Liver Disease and Obesity Treatment
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 3, pp. 220-228
Open Access | Times Cited: 111
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
Julio Plaza‐Díaz, Patricio Solis‐Urra, Fernando Rodríguez‐Rodríguez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8351-8351
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top